Top Industry Leaders in the Necrotizing Fasciitis Market
Latest Necrotizing Fasciitis Companies Update
Dec 2023Integra Life Science Launched their Surgicel® Absorbable Hemostat for use during NF surgeries, promoting efficient control of bleeding and tissue adhesion.Partnered with medical universities and hospitals to provide training on effective NF management and early diagnosis techniques.
Stryker Corporation Received FDA approval for their Surgilum® Advanced Absorbable Mesh, offering surgeons a versatile option for reconstructing tissues affected by NF.Collaborated with patient advocacy groups to raise awareness about NF symptoms and encourage timely medical attention.
Mölnlycke AB Introduced their Mepilex® Border Sacrum dressing specifically designed for managing NF wounds in challenging anatomical locations.Focused on developing advanced wound care solutions to optimize healing and minimize potential complications in NF patients.
Zimmer Biomet Holdings Expanded their portfolio of surgical tools and implants for NF surgeries, offering surgeons the necessary equipment for precise and effective debridement and reconstruction procedures.Invested in research and development of innovative medical devices for improved surgical intervention in complex NF cases.
Medtronic (UK) Introduced their Relia™Vac™ Advanced Negative Pressure Wound Therapy System, promoting enhanced wound healing and potentially reducing infection risks in NF patients.Partnered with healthcare institutions to implement their advanced wound therapy solutions for improved management of complex wounds like those associated with NF.
List of Necrotizing Fasciitis Key Companies in the Market
- Merck & Co. (U.S.)
- WOCKHARDT (India)
- Atox Bio (Israel)
- Teva Pharmaceutical Industries (Israel)
- Basilea Pharmaceutica Ltd. (Switzerland)
- MELINTA THERAPEUTICS, INC. (U.S.)